[1] BERNSTEIN R M, MORGAN S H, CHAPMAN J. Anti-Jo-1 antibody: a marker for myositis with interstitial lung disease [J]. British Medical Journal(Clinical Research Ed) 1984, 289.
[2] TARGOFF I N, REICHLIN M. Humoral immunity in polymyositis and dermatomyositis [J]. Mount Sinai Journal of Medicine 1988, 55.
[3] Ascherman DP, Oriss TB, Oddis CV, Wright TM. Critical Requirement for Professional APCs in Eliciting T Cell Responses to Novel Fragments of Histidyl-tRNA Synthetase (Jo-1) in Jo-1 Antibody-Positive Polymyositis. [J]. The Journal of Immunology: Official Journal of the American Association of Immunologists 2002, 12(12).
[4] Cusack S, HARTLEIN M, LEBERMAN R. Sequence, structural and evolutionar relationships between class 2 aminoacyl-tRNA synthetases [J]. Nucleic Acids Research 1991, 19.
[5] RABEN N, BORRIELLO F, AMIN J. Human histidyl-tRNA synthetase:recognition of amino acid signature regions in class 2 aminoacyl-tRNA synthetase [J]. Nucleic Acids Research 1992, 20.
[6] Shim H, TSUI F W L, RUBIN L A. Cellular localization of the target structures recognized by the anti-Jo-1 antibody immunofluorescence studies on cultured human myoblasts [J]. Journal of Rheumatology 1991, 18.
[7] 刘建荣. 蛋白酶K消化PCR产物提高克隆效率 [J]. 1997. |
